Literature DB >> 15541729

Estrogen regulation of trefoil factor 1 expression by estrogen receptor alpha and Sp proteins.

Jian-Min Sun1, Virginia A Spencer, Lin Li, Hou Yu Chen, Jenny Yu, James R Davie.   

Abstract

Estrogen-responsive genes in human breast cancer cells often have an estrogen response element (ERE) positioned next to an Sp1 binding site. In chromatin immunoprecipitation (ChIP) assays, we investigated the binding of estrogen receptor alpha (ER), Sp1, and Sp3 to the episomal and native estrogen-responsive trefoil factor 1 (TFF1; formerly pS2) promoter in MCF-7 breast cancer cells. Mutation of the Sp site upstream of the ERE reduced estrogen responsiveness and prevented binding of Sp1 and Sp3, but not ER to the episomal promoter. In the absence of estradiol (E2), Sp1, Sp3, histone deacetylase 1 (HDAC), and HDAC2, and low levels of acetylated H3 and H4 are associated with the native promoter, with the histones being engaged in dynamic reversible acetylation. Following E2 addition, levels of ER and acetylated H3 and H4 bound to the native promoter increases. There is clearance of Sp1, but not of Sp3, from the promoter while HDAC1 and HDAC2 remain bound. These data are consistent with a model in which Sp1 or Sp3 aid in recruitment of HDACs and histone acetyltransferases (HATs) to mediate dynamic acetylation of histones associated with the TFF1 promoter, which is in a state of readiness to respond to events occurring following the addition of estrogen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15541729     DOI: 10.1016/j.yexcr.2004.08.015

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  13 in total

Review 1.  Transcription in four dimensions: nuclear receptor-directed initiation of gene expression.

Authors:  Raphaël Métivier; George Reid; Frank Gannon
Journal:  EMBO Rep       Date:  2006-02       Impact factor: 8.807

2.  Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma.

Authors:  Nagarajan Kannan; Jian Kang; Xiangjun Kong; Jianzhong Tang; Jo K Perry; Kumarasamypet M Mohankumar; Lance D Miller; Edison T Liu; Hichem C Mertani; Tao Zhu; Prudence M Grandison; Dong-Xu Liu; Peter E Lobie
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

3.  Transplacental arsenic carcinogenesis in mice.

Authors:  Michael P Waalkes; Jie Liu; Bhalchandra A Diwan
Journal:  Toxicol Appl Pharmacol       Date:  2007-01-12       Impact factor: 4.219

4.  Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism.

Authors:  Jie Liu; Yaxiong Xie; Ryan Cooper; Danica M K Ducharme; Raymond Tennant; Bhalchandra A Diwan; Michael P Waalkes
Journal:  Toxicol Appl Pharmacol       Date:  2007-02-06       Impact factor: 4.219

5.  Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2.

Authors:  E Yang; J Cisowski; N Nguyen; K O'Callaghan; J Xu; A Agarwal; A Kuliopulos; L Covic
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

6.  Differential intranuclear organization of transcription factors Sp1 and Sp3.

Authors:  Shihua He; Jian-Min Sun; Lin Li; James R Davie
Journal:  Mol Biol Cell       Date:  2005-06-29       Impact factor: 4.138

7.  In vivo profiling of estrogen receptor/specificity protein-dependent transactivation.

Authors:  Fei Wu; Rui Xu; Kyounghyun Kim; James Martin; Stephen Safe
Journal:  Endocrinology       Date:  2008-07-17       Impact factor: 4.736

8.  Functional connection between deimination and deacetylation of histones.

Authors:  Hélène Denis; Rachel Deplus; Pascale Putmans; Michiyuki Yamada; Raphaël Métivier; François Fuks
Journal:  Mol Cell Biol       Date:  2009-07-06       Impact factor: 4.272

Review 9.  Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways.

Authors:  Stephen Safe; Kyounghyun Kim; Kyoungkim Kim
Journal:  J Mol Endocrinol       Date:  2008-09-04       Impact factor: 5.098

10.  Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) α and activator protein 1 (AP1) in dexamethasone-mediated interference of ERα activity.

Authors:  Sudipan Karmakar; Yetao Jin; Akhilesh K Nagaich
Journal:  J Biol Chem       Date:  2013-06-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.